John Croke

John Croke, CFA, is the head of multi-asset product management in Vanguard Portfolio Review Department, responsible for Vanguard Target Retirement Funds and the overall product strategy. He also partners with Vanguard Investment Strategy Group on asset allocation for Vanguard's global multi-asset class products. Before joining Vanguard, Mr. Croke was director of pension investments at Pfizer Inc. Before that role he was vice president of equity research at Jefferies & Company. Mr. Croke earned a B.S. in economics from Vanderbilt University and an M.B.A. in finance from New York University’s Stern School of Business. He is a CFA® charterholder and is a member of the CFA Institute and the New York Society of Security Analysts.

CFA® is a registered trademark owned by CFA Institute.

Recent posts

For more information about Vanguard funds or Vanguard ETFs, visit advisors.vanguard.com or call 800-997-2798 to obtain a prospectus or, if available, a summary prospectus. Investment objectives, risks, charges, expenses, and other important information are contained in the prospectus; read and consider it carefully before investing.

Vanguard ETF Shares are not redeemable with the issuing Fund other than in very large aggregations worth millions of dollars. Instead, investors must buy and sell Vanguard ETF Shares in the secondary market and hold those shares in a brokerage account. In doing so, the investor may incur brokerage commissions and may pay more than net asset value when buying and receive less than net asset value when selling.

Investments in bond funds are subject to interest rate, credit, and inflation risk.

Diversification does not ensure a profit or protect against a loss.

Investments in stocks or bonds issued by non-U.S. companies are subject to risks including country/regional risk and currency risk.

All investing is subject to risk, including possible loss of principal.